Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.verified

BCLI

Price:

$0.75

Market Cap:

$8.28M

Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to prompt mesenchymal stem cells, derived from the patient's own bone marrow, to produce high concentrations of neurotrophic factors. This process aims to regulate neuroinflammatory and neurodegenerative disease mechanisms, bolster the survival of neurons, and ultimately enhance neurological function. Nu...[Read more]

Industry

Biotechnology

IPO Date

2003-10-07

Stock Exchange

OTC

Ticker

BCLI

The ROE as of June 2026 (TTM) for Brainstorm Cell Therapeutics Inc. (BCLI) is 109.21%

According to Brainstorm Cell Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 109.21%. This represents a change of 269.35% compared to the average of 29.57% of the last 4 quarters.

Brainstorm Cell Therapeutics Inc. (BCLI) Historical ROE (quarterly & annually)

How has BCLI ROE performed in the past?

The mean historical ROE of Brainstorm Cell Therapeutics Inc. over the last ten years is 67.10%. The current 109.21% ROE has changed 62.75% with respect to the historical average. Over the past ten years (40 quarters), BCLI's ROE was at its highest in in the December 2022 quarter at 166.43%. The ROE was at its lowest in in the March 2019 quarter at -1542.02%.

Quarterly (TTM)
Annual

Average

67.10%

Median

-67.27%

Minimum

-278.07%

Maximum

805.21%

Brainstorm Cell Therapeutics Inc. (BCLI) ROE by Quarter and Year

Discovering the peaks and valleys of Brainstorm Cell Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 230.18%

Maximum Annual ROE = 805.21%

Minimum Annual Increase = -736.80%

Minimum Annual ROE = -278.07%

Quarterly (TTM)
Annual
YearROEChange
2025100.15%-166.90%
2024-149.70%-142.30%
2023353.89%-56.05%
2022805.21%-736.80%
2021-126.45%40.97%
2020-89.70%-147.15%
2019190.24%-168.41%
2018-278.07%230.18%
2017-84.22%67.39%
2016-50.31%-16.26%

Brainstorm Cell Therapeutics Inc. (BCLI) Average ROE

How has BCLI ROE performed in the past?

The current ROE of Brainstorm Cell Therapeutics Inc. (BCLI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

101.44%

5-year avg

196.62%

10-year avg

67.10%

Brainstorm Cell Therapeutics Inc. (BCLI) ROE vs. Peers

How is BCLI’s ROE compared to its peers?

Brainstorm Cell Therapeutics Inc.’s ROE is less than NeuroSense Therapeutics Ltd. (173.60%), greater than Matinas BioPharma Holdings, Inc. (-204.27%), greater than Adial Pharmaceuticals, Inc. (-162.83%), greater than Cardio Diagnostics Holdings, Inc. (-78.82%), greater than HCW Biologics Inc. (-102.39%), greater than Impact BioMedical Inc. (-2674.57%), greater than Acurx Pharmaceuticals, Inc. (-153.93%), greater than VYNE Therapeutics Inc. (-69.57%), greater than Addex Therapeutics Ltd (-102.62%), greater than BioCardia, Inc. (-5456.14%),

Build a custom stock screener for Brainstorm Cell Therapeutics Inc. (BCLI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brainstorm Cell Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Brainstorm Cell Therapeutics Inc. (BCLI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Brainstorm Cell Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Brainstorm Cell Therapeutics Inc.'s ROE?

How is the ROE calculated for Brainstorm Cell Therapeutics Inc. (BCLI)?

What is the highest ROE for Brainstorm Cell Therapeutics Inc. (BCLI)?

What is the 3-year average ROE for Brainstorm Cell Therapeutics Inc. (BCLI)?

What is the 5-year average ROE for Brainstorm Cell Therapeutics Inc. (BCLI)?

How does the current ROE for Brainstorm Cell Therapeutics Inc. (BCLI) compare to its historical average?